Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Hemoglobinopathies Companies

Hemoglobinopathies are a group of genetic disorders characterized by abnormalities in hemoglobin, the protein responsible for transporting oxygen in red blood cells. Conditions such as sickle cell disease and thalassemia are examples of hemoglobinopathies. Companies involved in hemoglobinopathies focus on developing diagnostics, treatments, and therapies to manage these genetic disorders.

Hemoglobinopathies Key Companies Latest Hemoglobinopathies Companies Update

April 2023: ECHO India, a non-profit organization dedicated to building India's healthcare capacity, has partnered with the Post Graduate Institute of Child Health (PGICH) to create a statewide initiative focusing on the prevention and control of beta thalassemia and other hemoglobinopathies. The program, which began today with a rigorous two-day Training of Trainers (ToT), will be conducted as part of a countrywide collaborative project. The National Hub for ECHO India's initiative will be PGICH, a prominent paediatric facility created. This effort intends to train healthcare personnel across the country in the prevention and management of Beta Thalassemia and other Hemoglobinopathies, with a focus on distant and disadvantaged areas.

February 2023: Vertex Therapeutics celebrated the launch of the first CRISPR-based gene editing medication as it nears completion of a historic FDA filing. Vertex estimates that a network of around 50 authorized treatment sites in the United States and 25 in Europe will be sufficient for its exagamglogene autotemcel, or exa-cel, gene therapy candidate for sickle cell disease and beta thalassemia. These individuals require many hospitalizations per year for vaso-occlusive crises or are dependent on blood transfusions on a regular basis. In November 2022, Vertex and CRISPR Therapeutics began submitting exa-cel for sickle cell disease and beta thalassemia. Outside of the United States, regulatory process has been a little speedier, since the European Medicines Agency and authorities in the United Kingdom have already confirmed the files.List of Hemoglobinopathies Key companies in the market

Sanofi

Sangamo Therapeutics, Inc.

Global Blood Therapeutics

Neusoft Medical Systems Co., Ltd

Bluebird Bio, Inc.

Emmaus Life Sciences Inc.

Prolong Pharmaceuticals

Celgene Corporation

Alnylam Pharmaceuticals

Gamida Cell

Acceleron Pharma

Mast Therapeutic

HemaQuest Pharmaceuticals

Hemoglobinopathies Market Highlights:

Hemoglobinopathies Market Size

Hemoglobinopathies Market Trends

Hemoglobinopathies Market Analysis

Hemoglobinopathies Market Share

Hemoglobinopathies Market Highlights:

Hemoglobinopathies Market Trends

Hemoglobinopathies Market Analysis

Hemoglobinopathies Market Share

Hemoglobinopathies Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.